Bec5® Curaderm Cream

Solasodine Glycosides Plant Ext Skin Fix (with optional Book) Dr Bill Cham
20ml (0.69 fl oz) Cream

Discovered and created by Dr Bill Cham... BEC5 Cream, also known as Curaderm, is an effective, convenient and non-invasive skin health topical cream. BEC5® is available exclusively at Ancient Purity and can be purchased with the official Bec-5 book.

£129.99 £108.32
In stock
EU/World Prices

Curaderm BEC5 Cream is An Effective Non-Surgical Skin Issue Treatment. BEC5 Curaderm contains a specially purified plant extract from the Solanum Sodomaeum from the Australasia region. The extract, known as Solasodine Glycosides is also found in the aubergine/eggplant but in much smaller quantities.

Aside from the estimated 80,000 people that have used BEC5 cream, there have been numerous clinical trials conducted in both Australia and Great Britain which have shown promising potential for BEC5. There have been a number of trials and test performed using Bec5 Cream, worth researching. We recommend adding the book on Bec-5 to your purchase.

BEC5® Curaderm Cream

  • Topical Cream - Easy to apply.
  • Contains Solasodine Glycosides (BEC).
  • Drivers Salicylic Acid and Urea.
  • Effective on keratosis (sun spots) and even age spots.
  • 20ml tube (lasts approximately 2-3 months).
  • No dangerous side effects and little to no scarring.
  • No fragrances or any other ingredients.
  • Curaderm BEC5 is extremely effective and the observed clinical cosmetic effects are incomparable.
  • Extensive, Imformative book optional.
bec-5 skin cancer

BEC5® Curaderm Cream Use

When undergoing treatment with Curaderm, people often think they have an infection but in majority of cases this is just the dead cells. Curaderm BEC5 contains Salicylic Acid & also Urea and these ingredients will help prevent you from any infection during treatment. During treatment with Curaderm if you are concerned you have an infection or you are just concerned, please consult your Doctor.

BEC5 should not be used on moles. Minimum use: seven days. Maximum use: three months. Avoid contact with your eyes. Do not use internally. Clean the area concerned with a mild antiseptic then dry and apply the BEC5 thickly over the area. Apply Curaderm BEC5 at least twice daily and cover the area with a micro-pore tape. Do not use for longer than three months, without a lengthy break. always consult with your Doctor or Healthcare practitioner before use.

Eggplant/Aubergine Plant Extracts used since 1825

BEC5® Curaderm Cream amazon UK buy supplier

There are reports that extracts of plants from the Solanaceae family of vegetables dating back to 1825, according to Dr. Jonathan Wright.

However, it wasn’t until after the 1950s, that they were formally studied.

The leading researcher in this area today is Dr. Bill E. Cham, who reported as early as 1991 - 
“A cream formulation containing high concentrations (10%) of a standard mixture of solasodine glycosides (BEC) has been shown to be effective for skin issues". 

The specific formulation BEC5, has been used successfully on more than 80,000 patients according to Dr. Cham.

Experience the Power of BEC5® Curaderm Cream - Order Today

BEC5® Curaderm Cream UK amazon UK
  • Clean the area of skin with a mild antiseptic to remove old skin cells.
  • Apply BEC5 relatively thickly to the area at least twice daily and cover with a micropore.
  • Continue to use the cream for a minimum of 7 days and a maximum of 60 days.
  • Note: Avoid the eyes. 
  • Brand: Curaderm Global.
  • Size: 20ml.
  • Container: Tube.
  • Storage: Keep out of reach of children.
  • Estimated shelf life from purchase: 2-3 years.
1985 Thorne, H.V., Clarke, G.F. and Skuce, R. (1985) The inactivation of herpes simplex virus by some Solanaceae glycoalkaloids. Antivirus Research, 5, 335-343. doi:10.1016/0166-3542(85)90003-8 1987 Cham, B.E. and Wilson, L. (1987) HPLC of glycoalkaloids from Solanum sodomaeum L. Planta Medica, 53, 59-61. doi:10.1055/s-2006-962621 Cham, B.E., Gilliver, M. and Wilson, L. (1987) Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum L. Planta Medica, 53, 34-36. doi:10.1055/s-2006-962612 Cham, B.E. and Meares, M.M. (1987) Glycoalkaloids from Solanum sodomaeum L. are effective in the treatment of skin cancers in man. Cancer Letters, 36, 111-118. doi:10.1016/0304-3835(87)90081-4 1990 Daunter, B. and Cham, B.E. (1990) Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells. Cancer Letters, 55, 209-220. doi:10.1016/0304-3835(90)90121-D Cham, B.E. and Daunter, B. (1990) Solasodine glycosides. Selective cytotoxicity for cancer cells and inhibition of cytotoxicity by rhamnose in mice with sarcoma 180. Cancer Letters, 55, 221-225. doi:10.1016/0304-3835(90)90122-E 1991 Cham, B.E., Daunter, B. and Evans, R. (1991) Topical treatment of malignant and premalignant skin cancers by very low concentrations of a standard mixture of solasodine glycosides. Cancer Letters, 59, 183-192. doi:10.1016/0304-3835(91)90140-D 1993 Cham, B.E. (1993) Efficacy and mode of action of solasodine glycosides (BEC) on cancer cells. Proceedings of 4th Oceania Symposium, Bioconcepts Publishing, 41- 51. 1994 Cham, B.E. (1994) Solasodine glycosides as anti-cancer agents: Pre-clinical and clinical studies. Asia Pacific Journal of Pharmacology, 9, 113-118. 1996 Nakamura, T., Komori, C., Lee, Y., Hashinoto, F., Yahara, S., Nohara T. and Ejina, A. (1996) Cytotoxic activities of Solanum steroidal glycosides. Biological Biopharmaceutical Bulletin, 19, 564-566. doi:10.1248/bpb.19.564 Hsu, S.H., Tsai, T.R., Lin, C.N., Yen, M.H. and Kuo, K.W. (1996) Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR1 which may lead to apoptosis. Biochemical and Biophysical Research Communication, 229, 1-5. doi:10.1006/bbrc.1996.1748 Chataing, B., Concepcion, J.L., Buitrago de Cristancho, N. and Usubillaga, A. (1996) Clinical study of the effectiveness of extracts alkaloids obtained of the fruits of Solanum americanum miller on herpes simplex, herpes two zoster and genital herpes. Rev. Fac Pharmacy, Univ. Los Andes, 32, 18-25. 1998 Chang, L.C., Tsai, T.R., Wang, J.J., Lin, C.N. and Kuo, K.W. (1998) The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis. Biochemical and Biophysical Research Communication, 242, 21-25. doi:10.1006/bbrc.1997.7903 1999 Kuo, K.W. and Lin, C.N. (1999) Pharmacological composition for treating cancer cells. US Patent No. 6214803. 2000 Kuo, K.W., Hsu, S.H., Li, Y.P., Lin, W.L., Liu, L.F., Chang, L.C., Lin, C.C., Lin, C.N. and Sheu, H.M. (2000) Anticancer activity evaluation of the Solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochemical Pharmacology, 60, 1865-1873. doi:10.1016/S0006-2952(00)00506-2 2002 Esteves-Souza, A., Silva T.M. and Alves, C.C.F. (2002) Cytotoxic activities against Ehrlich carcinoma and human K562 leukemia of alkaloids and flavonoid from two Solanum species. Journal of Brazil Chemical Society, 13, 838- 842. doi:10.1590/S0103-50532002000600017 Solbec Pty Ltd. http://www.solbec.com.au 2004 Lee, K.R., Kozukue, N.J., Han, S.J., Park, H., Chang, E.Y., Back, E.J., Chang J.S. and Friedman, M. (2004) Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. Journal of Agricultural Food Chemistry, 52, 2832-2839. doi:10.1021/jf030526d Liu, L.F., Liang, C.H., Shiu, L.Y., Lin, W.L., Lin, C.C. and Kuo, K.W. (2004) Action of solamargine on human lung cancer cells-enhancement of the susceptibility of cancer cells to TNFs. FEBS Letters, 577, 67-74. doi:10.1016/j.febslet.2004.09.064 2005 Lipscombe, R.J., Carter, S.J. and Ruane, M. (2005) Rhamnose binding protein. US Patent No. 6930171. Millward, M., Powell, A., Tyson, S., Daly, P., Ferguson, R. and Carter, S. (2005) Phase I trial of coramsine (SBP002) in patients with advanced solid tumours. Journal of Clinical Oncology, 23, 3105. 2006 He, D.J. (2006) Structure and anticancer activity of glycoalkaloids. Master’s Thesis. Ono, M., Nishimura, K.K., Suzuki, T., Fukushima, K., Igoshi, H., Yoshimitsu, H., Ikeda, T. and Nohara, T. (2006) Steroidal glycosides from the underground parts of Solanum sodomaeum. Chemical Pharmacy Bulletin, 54, 230-233. doi:10.1248/cpb.54.230 Millward, M., Powell, A., Daly, P., Tyson, R., Ferguson, R. and Carter, S. (2006) Results of phase I clinical trials of coramsine in patients with advanced solid tumours. Journal of Clinical Oncology, 24, 2070. 2007 Shiu, L.Y., Chang, L.C., Liang, C.H., Huang, Y.S., Sheu, H.M. and Kuo, K. W. (2007) Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chemical Toxicology, 45, 2155-2164. doi:10.1016/j.fct.2007.05.009 Liang, C.H., Shiu, L.Y., Chang, L.C., Sheu, H.M., Kuo, K.W. (2007) Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Molecular Nutrition Research, 51, 999-1005. doi:10.1002/mnfr.200700044 Cham, B.E. (2007) Review article. Solasodine rhamnosyl glycosides specificallybind cancer cell receptors and induce apoptosis and necrosis. Treatment for skin cancer and hope for internal cancers. Research Journal of Biological Sciences, 2,503-514. doi=rjbsci.2007.503.514 Cham, B.E. (2007) Solasodine rhamnosyl glycosides in a cream formulation is effective for treating large and troublesome skin cancers. Research Journal of Biological Sciences, 2, 749-761. doi=rjbsci.2007.749.761 2008 Cham, B.E. (2008) Cancer intralesion chemotherapy with solasodine rhamnosyl glycosides. Research Journal of Biological Science, 3(9), 1008-1017. doi=rjbsci.2008.1008.1017 Punjabi, S., Cook, L.J., Kersey, P., Marks R. and Cerio, R. (2008) Solasodine glycoalkaloids: A novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicentre study. International Journal of Dermatology, 47, 78-82. doi:10.1111/j.1365-4632.2007.03363.x 2009 Shiu, L.Y., Liang, C.H., Chang, L.C., Sheu, H.M., Tsai, E.M. and Kuo, K.W. (2009) Solamargine induces apoptosis and enhances susceptibility to trastazumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu. Bioscience Reports, 29, 35-45. doi:10.1042/BSR20080028 2010 Sun, L., Zhao, Y., Li, X., Yuan, H., Cheng, A. and Lou, H. (2010) A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells. Toxicology in Vitro, 24, 1504-1511. doi:10.1016/j.tiv.2010.07.013 Sun, L., Zhao, Y., Yuan, H., Li, X., Cheng A. and Lou, H. (2010) Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells. Cancer Chemotherapy Pharmacology, 65, 1125-1130. doi: 10.1007/s00280-010-1387-9 2011 Li, X., Zhao, Y., Wu, W.K.K., Liu, S., Cui, M. and Lou, H. (2011) Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U20S cells. Life Science, 88, 314-321. doi:10.1016/j.lfs.2010.12.006 Wang, Y., Gao, J., Gu, G., Li, G., Cui, C., Sun, B. and Lou, H. (2011) In situ RBLreceptor visualization and its mediated anticancer activity for solasodinerhamnosides. Chemistry Biochemistry, 12, 2418-2420. doi:10.1002/cbic.201100551 Li, X., Zhao, Y., Ji, M., Liu, S.S., Cui, M. and Lou, H.X. (2011) Induction of actin disruption and downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Molecular Nutrition Research, 51(8), 999-1005. doi: 10.1002/mnfr.200700044 Cham, B.E. (2011) Topical solasodine rhamnosyl glycosides derived from the eggplant treats large skin cancers: Two case reports. International Journal of Clinical Medicine, 2, 473-477. doi:10.4236/ijcm.2011.24080 Tavares, D.C., Munari, C.C., Araujo, M.G., Beltrame, M.C., Furtado, M.H., Goncalves, C.C., Tiossi, R.F., Bastos, J.K., Cunha, W.R. and Veneziani, R.C. (2011) Antimutagenic potential of Solanum lycocarpum against induction of chromosomal aberrations in V79 and micronuclei in mice by doxorubicin. Planta Medica, 77, 1489- 1494. doi:10.1055/s-0030-1270886 Tang, Z., Zhang, Y., Li, N., Xu, L., Zhao, B., Xiao, W., Wang, Z. and Bi, Y. (2011) Extraction, purification technology and antineoplastic effects of solamargine. Zhongguo Zhong Yao Za Zhi, Journal of Chinese Material Medicine, 36(16), 2192-2195. Wu, C.H., Liang, C.H., Shiu, L.Y., Chang, L.C., Lin, T.S., Lan, C.E.R., Tsai, J.C., Wong, T.W., Wei, K.J., Lin, T.K., Chang, N.S. and Sheu, H.M. (2011) Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway. Journal of Dermatological Science, 63, 83-92. doi: 10.1016/j.jdermsci.2011.04.003 Chase, T.R. (2011) Curaderm BEC5 for skin cancers, is it? An overview. Journal of Cancer Therapy, 2, 728-745. doi:10.4236/jct.2011.25099 Goldberg, L.H., Landau, J.M., Moody, M.N. and VergilisKalner, I.J. (2011) Treatment of Bowen’s disease on the penis with low concentration of a standard mixture of solasodine glycosides and liquid nitrogen. Dermatologic Surgery, 37, 858-861. doi:10.1111/j.1524-4725.2011.02014.x 2012 Cham, B.E. and Chase, T.R. (2012) Solasodine rhamnosyl glycosides cause apoptosis in cancer cells. Do they also prime the immune system resulting in long-term protection against cancer? Planta Medica, 78, 349-353. doi:10.1055/s-0031-1298149 Ding, X., Zhu, F.S., Li, M. and Gao, S.G. (2012) Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. Journal of Ethnopharmacology, 39, 599-604. doi:10.1016/j.jep.2011.11.058 Cham, B.E. (2012) Intralesion and Curaderm BEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or devil’s apple result in a rapid removal of large skin cancers. Methods of treatment compared. International Journal of Clinical Medicine, 3, 115-124. doi: 10.4236/ijcm.2012.32024 2013 Cham, B.E. (2013) Inspired by nature, proven by science. The new generation cancer treatment that causes cancer cells to commit suicide. Published. www.curadermbec5.com Cham, B.E. (2013) Solasodine glycosides: A topical therapy for actinic keratosis.A single-blind, randomized, placebo-controlled, parallel group study with CuradermBEC5 doi: 10.4236/jct.2013.42076 Cham, B.E. (2013) Topical CuradermBEC5 Skin Cancer: A Review of Clinical Outcomes. International Journal of Clinical Medicine, 4(5), 233-238. doi: 10.4236/ijcm.2013.45041 Cham, B.E. (2013) Drug Therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents. Modern Chemotherapy, 2(2), 33-49. doi: 10.4236/mc.2013.22005 2014 Cham, B.E. (2014) A Review of Solasodine Rhamnosides Therapy for Cancers on the Penis. British Journal of Medicine & Medical Research, 4(2), 621-631. doi: 10.9734/BJMMR/2014/4677

Disclaimer:

The products and the claims made about specific products, articles and claims made in the articles and information written on or through this site have not been evaluated by Ancient Purity, the MHRA, the FSA or the United States FDA and are not approved to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. Providing a product for sale does not imply Ancient Purity recommendation of that product, its suitability or its efficacy. Ancient Purity cannot give medical opinions. No comment or entry in this site or in any communication from Ancient Purity may be taken as such.

Prices and promotions are subject to change without notice. Customers should always carefully check all the details printed on the package before opening the product. Whilst all efforts are made to ensure accuracy of description, specifications and pricing there may be occasions where errors arise. Should such a situation occur the company cannot accept your order. In the event of a mistake you will be contacted with a full explanation and a corrected offer. The information displayed is considered as an invitation to treat not as a confirmed offer for sale. The contract is confirmed upon supply of goods, Prices and promotions are subject to change without notice.

Please read the Terms and Conditions of using this site, by using the site you are accepting the terms and conditions.
All Material on this site © 2014 Ancient Purity Ltd Registered in England & Wales 07801142 VAT Reg 168 335 488